Chest pain in patients with hypertrophic cardiomyopathy seems to be ca
used by relative myocardial ischemia due to the left ventricular outfl
ow pressure gradient and myocardial hypertrophy. However, in 2 cases o
f hypertrophic cardiomyopathy chest pain was associated with coronary
vasospasm. Thus, chest pain in these cases was decreased not by a beta
-blocker but by isosorbide dinitrate and a calcium antagonist. Because
beta-blockers are commonly used for hypertrophic obstructive cardiomy
opathy and chest pain may be aggravated by beta-blockers in patients w
ith coronary vasospasm, a combination of beta-blocker, isosorbide dini
trate and calcium antagonist was necessary for this hypertrophic cardi
omyopathy with variant angina.